Rituximab-containing therapy for chronic lymphocytic leukaemia

Lancet. 2011 Jan 15;377(9761):205; author reply 206. doi: 10.1016/S0140-6736(11)60042-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab